本页面由Tiger Trade Technology Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

18.94
+0.55002.99%
盘后18.940.00000.00%18:08 EDT
成交量:171.69万
成交额:3,228.33万
市值:24.21亿
市盈率:109.86
高:19.05
开:18.84
低:18.42
收:18.39
52周最高:30.48
52周最低:16.10
股本:1.28亿
流通股本:7,811.99万
量比:0.97
换手率:2.20%
股息:- -
股息率:- -
每股收益(TTM):0.1724
每股收益(LYR):0.1724
净资产收益率:7.48%
总资产收益率:3.53%
市净率:6.54
市盈率(LYR):109.86

数据加载中...

2026/03/02

重要事件披露

Form 8-K - Current report
2026/02/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/24

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities